Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Scientists Propose a New Lead for Alzheimer’s Research

By University of Adelaide | August 14, 2018

A University of Adelaide-led team of scientists has suggested a potential link between iron in our cells and the rare gene mutations that cause Alzheimer’s disease, which could provide new avenues for future research.

In a paper published in the journal Frontiers in Neuroscience, the team proposes a new theory for how rare gene mutations cause Alzheimer’s disease. A theory that, if proven, could assist in finding a way to prevent the crippling disease.

The researchers caution people against making choices about diet or supplements based on this idea, as their theory only relates to how cells handle iron, not how much iron is in a person’s diet.

Background

“For 20 years most scientists have believed that a small protein fragment, amyloid beta, causes Alzheimer’s disease,” says Associate Professor Michael Lardelli, School of Biological Sciences, the University of Adelaide.

“Clearing out amyloid beta from the brains of people who are developing Alzheimer’s disease can slow their rate of cognitive decline. But, so far, nothing has been able to stop the relentless progression of the disease,” he says.

A chance conversation between Associate Professor Lardelli, Dr Amanda Lumsden (South Australian Health and Medical Research Institute (SAHMRI) and Flinders University) and Dr Morgan Newman (the University of Adelaide) was the inspiration for the new theory of how mutations might cause Alzheimer’s disease.

Dr Lumsden has a background in the biology of how cells use iron, while the Adelaide researchers study the genes that cause Alzheimer’s disease when mutated.

After bringing their ideas to additional experts, such as Associate Professor Jack Rogers at Harvard Medical School and Dr Shohreh Majd of Flinders University, this group of researchers has now published a paper suggesting their new theory for how mutations might cause the rare but devastating, early onset form of Alzheimer’s disease that afflicts some families.

The New Theory

The team suggests that the abnormalities seen in inherited Alzheimer’s disease could result from problems in how neurons handle iron.

“Cells need iron to survive. In particular, iron is essential for the tiny powerhouses of all cells – the mitochondria – to generate most of the energy that keeps cells functioning,” says Associate Professor Lardelli.

“The genes mutated in inherited Alzheimer’s disease seem likely to affect how iron enters neurons, how it is recycled within neurons, and how it is exported from neurons.

“Since neurons have such huge energy needs, disturbing the way they handle iron can have serious, long-term consequences.

“Furthermore, iron is a key player in inflammation and in the production of damaging molecules named ‘reactive oxygen species’, and both occur at high levels in brains with Alzheimer’s disease,” says Associate Professor Lardelli.

While the researchers see intriguing connections between iron and Alzheimer’s disease, further investigation will be required to understand how mutations that cause the disease affect cellular iron.

(Source: University of Adelaide)


Filed Under: Neurological Disease

 

Related Articles Read More >

Novo Nordisk in the Drug Discovery & Development Pharma 50
Novo Alzheimer’s trial disappoints as amycretin shines
Shifting mindsets all around: clinical thinking about Alzheimer’s disease moves from symptoms treatment toward earlier intervention and prevention
Quanterix VP: Why biomarkers are no longer supplemental
Texas sues Kenvue claiming it hid link between Tylenol and autism
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE